JACOB SCOTT: Open Payments
NPI 1801314356 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,624 in 111 payments from 12 companies in 2025. Trend: 2023 $569 · 2024 $585 · 2025 $1,624
Food & beverage: $1,616Education: $8
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $400 |
| Supernus Pharmaceuticals, Inc. | 20 | $307 |
| ABBVIE INC. | 13 | $197 |
| Otsuka America Pharmaceutical, Inc. | 15 | $172 |
| Axsome Therapeutics, Inc. | 10 | $149 |
| Corium, LLC | 13 | $134 |
| Alkermes, Inc. | 4 | $95 |
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| HARMONY BIOSCIENCES LLC | 1 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
Products named: CAPLYTA, Qelbree, VRAYLAR, REXULTI, Auvelity, Azstarys, ARISTADA, FANAPT.
Industry payments across AL — which companies pay providers there.
